Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引：0
|
作者：
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构：
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2022年 / 122卷 / 01期
关键词：
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I：
10.1007/s13760-021-01846-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [41] Aβ1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible Aβ1-42 aggregation?
    Sancesario, Giulia M.
    Esposito, Zaira
    Nuccetelli, Marzia
    Bernardini, Sergio
    Sorge, Roberto
    Martorana, Alessandro
    Federici, Giorgio
    Bernardi, Giorgio
    Sancesario, Giuseppe
    EXPERIMENTAL NEUROLOGY, 2010, 223 (02) : 371 - 376
  • [42] Plasma betacarotene in Alzheimer's disease.: Association with cerebrospinaffluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau
    Stuerenburg, HJ
    Ganzer, S
    Müller-Thomsen, T
    NEUROENDOCRINOLOGY LETTERS, 2005, 26 (06) : 696 - 698
  • [43] Total-tau, Aβ1-42 and Ubiquitin in CSF in the diagnosis of Alzheimer disease
    Iqbal, K
    EUROPEAN PSYCHIATRY, 2002, 17 : 76S - 76S
  • [44] A CALHM1 Polymorphism Associated with Late-Onset Alzheimer's Disease Predicts Elevations in CSF Aβ1-40 and Aβ1-42 in Healthy Normal Controls
    Koppel, Jeremy
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A105 - A106
  • [45] Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease
    Lista, Simone
    Emanuele, Enzo
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 411 - 413
  • [46] Plasma amyloid β-peptide 1-42 and incipient Alzheimer's disease
    Mayeux, R
    Tang, MX
    Jacobs, DM
    Manly, J
    Bell, K
    Merchant, C
    Small, SA
    Stern, Y
    Wisniewski, HM
    Mehta, PD
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 412 - 416
  • [47] Aggregation States of Aβ1-40, Aβ1-42 and Aβp3-42 Amyloid Beta Peptides: A SANS Study
    Festa, Giulia
    Mallamace, Francesco
    Sancesario, Giulia Maria
    Corsaro, Carmelo
    Mallamace, Domenico
    Fazio, Enza
    Arcidiacono, Laura
    Sakai, Victoria Garcia
    Senesi, Roberto
    Preziosi, Enrico
    Sancesario, Giuseppe
    Andreani, Carla
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
  • [48] Molecular simulation of the amyloid β-peptide Aβ-(1-40) of Alzheimer's disease
    Mager, PP
    MOLECULAR SIMULATION, 1998, 20 (04) : 201 - +
  • [49] Towards point-of-care diagnosis of Alzheimer's disease: Multi-analyte based portable chemiresistive platform for simultaneous detection of β-amyloid (1-40) and (1-42) in plasma
    Supraja, Patta
    Tripathy, Suryasnata
    Singh, Ranjana
    Singh, Vikrant
    Chaudhury, Gajendranath
    Singh, Shiv Govind
    BIOSENSORS & BIOELECTRONICS, 2021, 186
  • [50] CSF amyloid β 1-42 predicts cognitive decline in Parkinson's disease
    Siderowf, A.
    Xie, S. X.
    Hurtig, H. I.
    Weintraub, D.
    Duda, J. E.
    Chen-Plotkin, A.
    Shaw, L. M.
    Van Deerlin, V.
    Trojanowski, J. Q.
    Clark, C. M.
    MOVEMENT DISORDERS, 2010, 25 (07) : S205 - S205
12345